Listed

Mesa Laboratories Inc

MLABNasdaqCIK 724004TechnologyFiscal year ends Mar 31

Latest reported revenue, Q1 FY2027$60.1mRevenue, Q1 FY2027, three months to 2026-06-30$60.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 10, 2026.

Latest quarter: Q1 FY2027

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$60.1mRevenue, Q1 FY2027, three months to 2026-06-30$60.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Report this figure+1.0% on a year earlier
  • Gross margin64.9%Gross margin, Q1 FY2027, three months to 2026-06-30. gross profit / revenueGross profit: $39.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Revenue: $60.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Report this figure+2.8 pts on a year earlier
  • Operating margin11.7%Operating margin, Q1 FY2027, three months to 2026-06-30. operating income / revenueOperating income: $7.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Revenue: $60.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Report this figure+6.5 pts on a year earlier
  • Net margin4.7%Net margin, Q1 FY2027, three months to 2026-06-30. net income / revenueNet income: $2.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Revenue: $60.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Report this figure−3.3 pts on a year earlier
  • Diluted EPS$0.49Diluted EPS, Q1 FY2027, three months to 2026-06-30$0.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Report this figure−42.4% on a year earlier
  • Free cash flow$14.2mFree cash flow, Q1 FY2027, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $14.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Capital expenditure: $559.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Report this figure+1503.7% on a year earlier

Last eight quarters

Full statements
Revenue$60.1mGross margin 64.9%
Diluted EPS$0.49, Q1 FY2027
Free cash flow$14.2m, Q1 FY2027
Mesa Laboratories Inc, key figures for the last eight quarters
Line itemUnitQ2 FY20252024-09-30Q3 FY20252024-12-31Q4 FY20252025-03-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q3 FY20262025-12-31Q4 FY20262026-03-31Q1 FY20272026-06-30Shape over the periods
Revenue$m57.8Revenue, Q2 FY2025, three months to 2024-09-30$57.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0000724004-25-000013.Report this figure62.8Revenue, Q3 FY2025, three months to 2024-12-31$62.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-03, accession 0000724004-26-000016.Report this figure62.1Revenue, Q4 FY2025, three months to 2025-03-31$62.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-03, accession 0000724004-26-000047. Derived: 12-month figure less the 9-month figure.Report this figure59.5Revenue, Q1 FY2026, three months to 2025-06-30$59.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Report this figure60.7Revenue, Q2 FY2026, three months to 2025-09-30$60.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0000724004-25-000013.Report this figure65.1Revenue, Q3 FY2026, three months to 2025-12-31$65.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-03, accession 0000724004-26-000016.Report this figure63.7Revenue, Q4 FY2026, three months to 2026-03-31$63.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-03, accession 0000724004-26-000047. Derived: 12-month figure less the 9-month figure.Report this figure60.1Revenue, Q1 FY2027, three months to 2026-06-30$60.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Report this figure
Gross margin%61.3%Gross margin, Q2 FY2025, three months to 2024-09-30. gross profit / revenueGross profit: $35.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0000724004-25-000013.Revenue: $57.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0000724004-25-000013.Report this figure63.3%Gross margin, Q3 FY2025, three months to 2024-12-31. gross profit / revenueGross profit: $39.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-03, accession 0000724004-26-000016.Revenue: $62.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-03, accession 0000724004-26-000016.Report this figure61.8%Gross margin, Q4 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $38.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-06-03, accession 0000724004-26-000047. Derived: 12-month figure less the 9-month figure.Revenue: $62.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-03, accession 0000724004-26-000047. Derived: 12-month figure less the 9-month figure.Report this figure62.0%Gross margin, Q1 FY2026, three months to 2025-06-30. gross profit / revenueGross profit: $36.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Revenue: $59.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Report this figure61.5%Gross margin, Q2 FY2026, three months to 2025-09-30. gross profit / revenueGross profit: $37.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0000724004-25-000013.Revenue: $60.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0000724004-25-000013.Report this figure64.2%Gross margin, Q3 FY2026, three months to 2025-12-31. gross profit / revenueGross profit: $41.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-03, accession 0000724004-26-000016.Revenue: $65.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-03, accession 0000724004-26-000016.Report this figure66.2%Gross margin, Q4 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $42.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-06-03, accession 0000724004-26-000047. Derived: 12-month figure less the 9-month figure.Revenue: $63.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-03, accession 0000724004-26-000047. Derived: 12-month figure less the 9-month figure.Report this figure64.9%Gross margin, Q1 FY2027, three months to 2026-06-30. gross profit / revenueGross profit: $39.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Revenue: $60.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Report this figure
Operating margin%6.1%Operating margin, Q2 FY2025, three months to 2024-09-30. operating income / revenueOperating income: $3.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0000724004-25-000013.Revenue: $57.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0000724004-25-000013.Report this figure9.2%Operating margin, Q3 FY2025, three months to 2024-12-31. operating income / revenueOperating income: $5.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-03, accession 0000724004-26-000016.Revenue: $62.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-03, accession 0000724004-26-000016.Report this figure2.4%Operating margin, Q4 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-06-03, accession 0000724004-26-000047. Derived: 12-month figure less the 9-month figure.Revenue: $62.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-03, accession 0000724004-26-000047. Derived: 12-month figure less the 9-month figure.Report this figure5.1%Operating margin, Q1 FY2026, three months to 2025-06-30. operating income / revenueOperating income: $3.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Revenue: $59.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Report this figure7.8%Operating margin, Q2 FY2026, three months to 2025-09-30. operating income / revenueOperating income: $4.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0000724004-25-000013.Revenue: $60.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0000724004-25-000013.Report this figure12.2%Operating margin, Q3 FY2026, three months to 2025-12-31. operating income / revenueOperating income: $8.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-03, accession 0000724004-26-000016.Revenue: $65.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-03, accession 0000724004-26-000016.Report this figure4.3%Operating margin, Q4 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $2.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-06-03, accession 0000724004-26-000047. Derived: 12-month figure less the 9-month figure.Revenue: $63.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-03, accession 0000724004-26-000047. Derived: 12-month figure less the 9-month figure.Report this figure11.7%Operating margin, Q1 FY2027, three months to 2026-06-30. operating income / revenueOperating income: $7.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Revenue: $60.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Report this figure
Net margin%5.9%Net margin, Q2 FY2025, three months to 2024-09-30. net income / revenueNet income: $3.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-03, accession 0000724004-26-000016.Revenue: $57.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0000724004-25-000013.Report this figure(2.7%)Net margin, Q3 FY2025, three months to 2024-12-31. net income / revenueNet income: −$1.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-03, accession 0000724004-26-000016.Revenue: $62.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-03, accession 0000724004-26-000016.Report this figure(11.4%)Net margin, Q4 FY2025, three months to 2025-03-31. net income / revenueNet income: −$7.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-06-03, accession 0000724004-26-000047. Derived: 12-month figure less the 9-month figure.Revenue: $62.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-03, accession 0000724004-26-000047. Derived: 12-month figure less the 9-month figure.Report this figure8.0%Net margin, Q1 FY2026, three months to 2025-06-30. net income / revenueNet income: $4.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Revenue: $59.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Report this figure4.1%Net margin, Q2 FY2026, three months to 2025-09-30. net income / revenueNet income: $2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-03, accession 0000724004-26-000016.Revenue: $60.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0000724004-25-000013.Report this figure5.6%Net margin, Q3 FY2026, three months to 2025-12-31. net income / revenueNet income: $3.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-03, accession 0000724004-26-000016.Revenue: $65.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-03, accession 0000724004-26-000016.Report this figure(6.5%)Net margin, Q4 FY2026, three months to 2026-03-31. net income / revenueNet income: −$4.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-06-03, accession 0000724004-26-000047. Derived: 12-month figure less the 9-month figure.Revenue: $63.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-03, accession 0000724004-26-000047. Derived: 12-month figure less the 9-month figure.Report this figure4.7%Net margin, Q1 FY2027, three months to 2026-06-30. net income / revenueNet income: $2.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Revenue: $60.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Report this figure
Diluted EPS$ per share0.63Diluted EPS, Q2 FY2025, three months to 2024-09-30$0.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0000724004-25-000013.Report this figure(0.31)Diluted EPS, Q3 FY2025, three months to 2024-12-31−$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-03, accession 0000724004-26-000016.Report this figurenot reported (Diluted EPS not reported)0.85Diluted EPS, Q1 FY2026, three months to 2025-06-30$0.85 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Report this figure0.45Diluted EPS, Q2 FY2026, three months to 2025-09-30$0.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0000724004-25-000013.Report this figure0.65Diluted EPS, Q3 FY2026, three months to 2025-12-31$0.65 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-03, accession 0000724004-26-000016.Report this figurenot reported (Diluted EPS not reported)0.49Diluted EPS, Q1 FY2027, three months to 2026-06-30$0.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Report this figure
Free cash flow$m3.5Free cash flow, Q2 FY2025, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $5.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0000724004-25-000013. Derived: 6-month figure less the 3-month figure.Capital expenditure: $1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0000724004-25-000013. Derived: 6-month figure less the 3-month figure.Report this figure17.3Free cash flow, Q3 FY2025, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $18.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-03, accession 0000724004-26-000016. Derived: 9-month figure less the 6-month figure.Capital expenditure: $813.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-03, accession 0000724004-26-000016. Derived: 9-month figure less the 6-month figure.Report this figure11.9Free cash flow, Q4 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $12.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-03, accession 0000724004-26-000047. Derived: 12-month figure less the 9-month figure.Capital expenditure: $757.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-06-03, accession 0000724004-26-000047. Derived: 12-month figure less the 9-month figure.Report this figure0.9Free cash flow, Q1 FY2026, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $1.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Capital expenditure: $1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Report this figure7.1Free cash flow, Q2 FY2026, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $8.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0000724004-25-000013. Derived: 6-month figure less the 3-month figure.Capital expenditure: $1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0000724004-25-000013. Derived: 6-month figure less the 3-month figure.Report this figure18.0Free cash flow, Q3 FY2026, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $18.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-03, accession 0000724004-26-000016. Derived: 9-month figure less the 6-month figure.Capital expenditure: $732.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-03, accession 0000724004-26-000016. Derived: 9-month figure less the 6-month figure.Report this figure13.5Free cash flow, Q4 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $14.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-03, accession 0000724004-26-000047. Derived: 12-month figure less the 9-month figure.Capital expenditure: $417.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-06-03, accession 0000724004-26-000047. Derived: 12-month figure less the 9-month figure.Report this figure14.2Free cash flow, Q1 FY2027, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $14.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Capital expenditure: $559.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-10, accession 0001437749-26-026808.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$249.1mGross margin 63.5%
Diluted EPS$1.21, FY2026
Free cash flow$39.6m, FY2026
Mesa Laboratories Inc, key figures for the last five fiscal years
Line itemUnitFY20222022-03-31FY20232023-03-31FY20242024-03-31FY20252025-03-31FY20262026-03-31Shape over the periods
Revenue$m184Revenue, FY2022, twelve months to 2022-03-31$184.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-06-28, accession 0001437749-24-021606.Report this figure219Revenue, FY2023, twelve months to 2023-03-31$219.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-05-28, accession 0001437749-25-018586.Report this figure216Revenue, FY2024, twelve months to 2024-03-31$216.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-03, accession 0000724004-26-000047.Report this figure241Revenue, FY2025, twelve months to 2025-03-31$241.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-03, accession 0000724004-26-000047.Report this figure249Revenue, FY2026, twelve months to 2026-03-31$249.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-03, accession 0000724004-26-000047.Report this figure
Gross margin%59.2%Gross margin, FY2022, twelve months to 2022-03-31. gross profit / revenueGross profit: $109.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-06-28, accession 0001437749-24-021606.Revenue: $184.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-06-28, accession 0001437749-24-021606.Report this figure61.0%Gross margin, FY2023, twelve months to 2023-03-31. gross profit / revenueGross profit: $133.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-05-28, accession 0001437749-25-018586.Revenue: $219.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-05-28, accession 0001437749-25-018586.Report this figure61.6%Gross margin, FY2024, twelve months to 2024-03-31. gross profit / revenueGross profit: $133.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-06-03, accession 0000724004-26-000047.Revenue: $216.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-03, accession 0000724004-26-000047.Report this figure62.6%Gross margin, FY2025, twelve months to 2025-03-31. gross profit / revenueGross profit: $150.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-06-03, accession 0000724004-26-000047.Revenue: $241.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-03, accession 0000724004-26-000047.Report this figure63.5%Gross margin, FY2026, twelve months to 2026-03-31. gross profit / revenueGross profit: $158.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-06-03, accession 0000724004-26-000047.Revenue: $249.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-03, accession 0000724004-26-000047.Report this figure
Operating margin%2.6%Operating margin, FY2022, twelve months to 2022-03-31. operating income / revenueOperating income: $4.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-06-28, accession 0001437749-24-021606.Revenue: $184.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-06-28, accession 0001437749-24-021606.Report this figure1.5%Operating margin, FY2023, twelve months to 2023-03-31. operating income / revenueOperating income: $3.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-05-28, accession 0001437749-25-018586.Revenue: $219.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-05-28, accession 0001437749-25-018586.Report this figure(125.9%)Operating margin, FY2024, twelve months to 2024-03-31. operating income / revenueOperating income: −$272.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-06-03, accession 0000724004-26-000047.Revenue: $216.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-03, accession 0000724004-26-000047.Report this figure6.8%Operating margin, FY2025, twelve months to 2025-03-31. operating income / revenueOperating income: $16.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-06-03, accession 0000724004-26-000047.Revenue: $241.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-03, accession 0000724004-26-000047.Report this figure7.4%Operating margin, FY2026, twelve months to 2026-03-31. operating income / revenueOperating income: $18.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-06-03, accession 0000724004-26-000047.Revenue: $249.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-03, accession 0000724004-26-000047.Report this figure
Net margin%1.0%Net margin, FY2022, twelve months to 2022-03-31. net income / revenueNet income: $1.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-06-28, accession 0001437749-24-021606.Revenue: $184.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-06-28, accession 0001437749-24-021606.Report this figure0.4%Net margin, FY2023, twelve months to 2023-03-31. net income / revenueNet income: $930.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-05-28, accession 0001437749-25-018586.Revenue: $219.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-05-28, accession 0001437749-25-018586.Report this figure(117.6%)Net margin, FY2024, twelve months to 2024-03-31. net income / revenueNet income: −$254.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-06-03, accession 0000724004-26-000047.Revenue: $216.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-03, accession 0000724004-26-000047.Report this figure(0.8%)Net margin, FY2025, twelve months to 2025-03-31. net income / revenueNet income: −$2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-06-03, accession 0000724004-26-000047.Revenue: $241.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-03, accession 0000724004-26-000047.Report this figure2.7%Net margin, FY2026, twelve months to 2026-03-31. net income / revenueNet income: $6.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-06-03, accession 0000724004-26-000047.Revenue: $249.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-03, accession 0000724004-26-000047.Report this figure
Diluted EPS$ per share0.35Diluted EPS, FY2022, twelve months to 2022-03-31$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-06-28, accession 0001437749-24-021606.Report this figure0.17Diluted EPS, FY2023, twelve months to 2023-03-31$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-05-28, accession 0001437749-25-018586.Report this figure(47.20)Diluted EPS, FY2024, twelve months to 2024-03-31−$47.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-06-03, accession 0000724004-26-000047.Report this figure(0.36)Diluted EPS, FY2025, twelve months to 2025-03-31−$0.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-06-03, accession 0000724004-26-000047.Report this figure1.21Diluted EPS, FY2026, twelve months to 2026-03-31$1.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-06-03, accession 0000724004-26-000047.Report this figure
Free cash flow$m34.8Free cash flow, FY2022, twelve months to 2022-03-31. operating cash flow − capital expenditureOperating cash flow: $39.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-06-28, accession 0001437749-24-021606.Capital expenditure: $4.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-06-28, accession 0001437749-24-021606.Report this figure23.4Free cash flow, FY2023, twelve months to 2023-03-31. operating cash flow − capital expenditureOperating cash flow: $28.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-05-28, accession 0001437749-25-018586.Capital expenditure: $4.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-05-28, accession 0001437749-25-018586.Report this figure41.6Free cash flow, FY2024, twelve months to 2024-03-31. operating cash flow − capital expenditureOperating cash flow: $44.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-03, accession 0000724004-26-000047.Capital expenditure: $2.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-06-03, accession 0000724004-26-000047.Report this figure42.6Free cash flow, FY2025, twelve months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $46.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-03, accession 0000724004-26-000047.Capital expenditure: $4.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-06-03, accession 0000724004-26-000047.Report this figure39.6Free cash flow, FY2026, twelve months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $42.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-03, accession 0000724004-26-000047.Capital expenditure: $3.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-06-03, accession 0000724004-26-000047.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Mesa Laboratories Inc
FundQuarter endedReported valueSharesPut or callChange on the quarter before
Long Path Partners LP2026-06-30$47.5m477,126Added+71,543
BlackRock, Inc.2026-06-30$43.9m440,552Added+46,701
Boston Partners2026-06-30$26.4m265,149Reduced−3,562
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$23.6m237,457Added+4,814
AQR CAPITAL MANAGEMENT LLC2026-06-30$20.3m203,739Added+33,177
Ranger Investment Management, L.P.2026-06-30$17.3m173,988Reduced−28,915
MORGAN STANLEY2026-06-30$15.6m156,979Reduced−5,137
Diamond Hill Capital Management, LLC (Investment Advisor)2026-06-30$15.5m155,771Added+469
RAYMOND JAMES FINANCIAL INC2026-06-30$14.9m149,937Added+27,026
DIMENSIONAL FUND ADVISORS LP2026-06-30$14.8m148,395Added+23,765

Recent filings

All 1,103 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Mesa Laboratories Inc, recent filings
FiledFormWhat it isAccession number
2026-10-1308:00 ET8-K2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-26-032499
2026-09-0815:26 ET8-K5.07 Shareholder vote results0001437749-26-029813
2026-08-1017:17 ET10-QQuarterly reportPeriod 2026-06-300001437749-26-026808
2026-08-1016:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-26-026769
2026-07-3017:18 ET8-K5.05 Item not in the standard list; 9.01 Financial statements and exhibits0000724004-26-000082
2026-07-2214:55 ETDEF 14AProxy statementPeriod 2026-09-080000724004-26-000071
2026-06-1517:29 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000724004-26-000056
2026-06-0318:19 ET10-KAnnual reportPeriod 2026-03-310000724004-26-000047
2026-05-2708:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000724004-26-000039
2026-03-2316:25 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000724004-26-000030

Latest annual report

Form 10-K for the fiscal year ended Mar 31, 2026Filed Jun 3, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q2 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
724004
Tickers
MLAB
Exchange
Nasdaq
SIC code
3823 Industrial Instruments For Measurement, Display, and Control
Sector
Technology
Fiscal year ends
Mar 31
Incorporated in
CO
Filer category
Accelerated filer
Former names
MESA LABORATORIES INC /CO (to 2020-08-28)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 18:36 ET. Listed shows no prices and gives no investment advice.